Risk-Based Validation in Biopharma: Applying ICH Q9, Q10 & Q12 Effectively
In biopharmaceutical manufacturing, not all processes and equipment carry the same risk. Yet, traditional validation approaches often treat them equally, leading to unnecessary effort, cost, and documentation. Risk-Based Validation (RBV) addresses this by focusing resources on areas that matter most for product quality and patient safety.